| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $93K | -22.5% |
| Cost of Revenue | $50K | -35.1% |
| Gross Profit | $43K | +0.0% |
| R&D Expense | $70.5M | +85.3% |
| SG&A Expense | $23.1M | +79.9% |
| Operating Income | -$93.5M | -84.0% |
| Income Tax | $0 | — |
| Net Income | -$68.7M | +10.9% |
| EPS (Basic) | -$1.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.5M | +103.1% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $73K | +0.0% |
| Current Assets | $71.8M | +101.3% |
| Total Assets | $108.1M | +41.8% |
| Current Liabilities | $19.8M | +76.8% |
| Total Liabilities | $79.7M | -30.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.5M | -53.0% |
| Capital Expenditures | $1.8M | +391.6% |
| Investing Cash Flow | -$1.8M | -391.6% |
| Financing Cash Flow | $101.2M | +268.9% |
| Free Cash Flow | -$67.3M | -55.8% |
| +96.4% |
| EPS (Diluted) | -$1.62 | +96.4% |
| Stockholders' Equity |
| $28.4M |
| +108.7% |